Hair Follicle Stem Cells as Neuro Treatment

Skin2Neuron (S2N) is pioneering a novel approach to regenerative medicine, focusing on the development of Hair Follicle-derived Neuroprecursor (HFN) cells for treating neurodegenerative diseases, particularly Alzheimer’s dementia. These HFN cells, which are derived from human hair follicles, possess the unique ability to differentiate exclusively into neurons, making them a promising candidate for neurorestorative therapies. S2N's innovative methodology allows for the isolation, purification, and expansion of these cells, enabling the creation of personalized cell therapies. The company has demonstrated the efficacy of HFN cells through extensive research, including successful veterinary trials that showed significant improvements in canine patients suffering from dementia-like syndromes.

S2N's technology diverges from traditional approaches that target amyloid plaques, instead addressing the fundamental issue of lost neurons and synapses. Their therapeutic strategy involves microinjecting HFN cells directly into the hippocampus, the brain's memory center, which has shown promising results in preclinical studies. The company is also exploring the potential of HFN cell therapy for other neurodegenerative conditions, such as Parkinson’s and Huntington’s diseases. With a commitment to advancing their research into human clinical trials, S2N aims to transform the landscape of neurorestorative medicine and improve the quality of life for individuals affected by these debilitating conditions.

Australia

S2N’s vision is a world where neuronal loss no longer means loss.  Our regenerative medicine technology starts with the human hair follicle and ends with production of millions of pure neurons, all gene modification free. We aim to transform health, science and society.

Skin2Neuron

Company Details